Dyslipidemia and Cardiovascular Disease Risk Factor Management in HIV-1-Infected Subjects Treated with HAART in the Spanish VACH Cohort

BACKGROUND: There is increasing evidence that metabolic adverse effects associated with antiretroviral therapy may translate into an increased cardiovascular risk in HIV-1-infected patients. OBJECTIVES: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-1-infected...

Descripción completa

Detalles Bibliográficos
Autores principales: Domingo, Pere, Suarez-Lozano, Ignacio, Teira, Ramón, Lozano, Fernando, Terrón, Alberto, Viciana, Pompeyo, González, Juan, Galindo, Mª José, Geijo, Paloma, Vergara, Antonio, Cosín, Jaime, Ribera, Esteban, Roca, Bernardino, Garcia-Alcalde, Mª Luisa, Sánchez, Trinitario, Torres, Ferran, Lacalle, Juan Ramón, Garrido, Myriam
Formato: Texto
Lenguaje:English
Publicado: Bentham Science Publishers Ltd. 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556198/
https://www.ncbi.nlm.nih.gov/pubmed/18923695
http://dx.doi.org/10.2174/1874613600802010026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556198/
https://www.ncbi.nlm.nih.gov/pubmed/18923695
http://dx.doi.org/10.2174/1874613600802010026

Ejemplares similares